Age and A1C Are Important Clinical Predictors of Continuous Subcutaneous Insulin Infusion Efficacy in Type 1 Diabetic Patients

Diabetes Care - United States
doi 10.2337/diacare.28.7.1834
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Continuous Subcutaneous Insulin Infusion

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1997English

Continuous Subcutaneous Insulin Infusion

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Consequences of Delayed Pump Infusion Line Change in Patients With Type 1 Diabetes Mellitus Treated With Continuous Subcutaneous Insulin Infusion

Journal of Diabetes and its Complications
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Clinical and Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion for Diabetes

Health Technology Assessment
MedicineHealth Policy
2004English

Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy vs Continuous Subcutaneous Insulin Infusion in Patients With Type 1 Diabetes in the Netherlands

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy

Canadian Journal of Diabetes
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy